Petauri has acquired Emotive, a global medical communications agency specializing in scientific, strategic, and creative services for the pharmaceutical industry. The transaction expands Petauri’s international capabilities and strengthens its Petauri Advance medical communications business, which supports pharmaceutical companies throughout the development and commercialization of complex therapies.
Founded in 2013, Emotive has developed expertise in communicating scientific information involving neuroscience, immunology, oncology, rare diseases, and other therapeutic areas.
Its services combine scientific knowledge with strategic communications and creative development.
The business works with life sciences companies seeking to communicate information about medical research, treatments, and disease management to healthcare professionals and other audiences.
The acquisition will integrate Emotive into Petauri Advance, the company’s medical communications collective.
Existing agencies within the organization include DRIVE, PROPEL, MOMENTUM, BluPrint Oncology, Verascity Science, and Cogency.
The addition will expand the group’s capacity to support medical communications across multiple countries and therapeutic categories.
Petauri Advance provides services involving strategic planning, medical insights, disease education, promotional communications, scientific publications, and professional medical meetings.
Its activities also include supporting congresses and symposia where new research and treatment developments are discussed.
These services can be important for pharmaceutical companies introducing treatments involving complex scientific information.
Healthcare professionals, payers, and other stakeholders require access to relevant clinical evidence to evaluate new medicines.
Medical communications agencies help life sciences companies organize and communicate that information across different formats and channels.
Petauri believes Emotive’s expertise will strengthen its ability to provide these services through a coordinated international platform.
The acquisition also brings additional leadership experience to the organization.
Chris Edmonds, Founder and CEO of Emotive, will serve as Executive Advisor within Petauri following the transaction.
His continued involvement is intended to support integration and maintain relationships with Emotive’s clients.
Petauri was established in 2023 by CEO Dan Renick in partnership with Oak Hill Capital.
The company is building a platform of pharmaceutical services businesses specializing in medical communications, market access, and related advisory capabilities.
Since its founding, Petauri has launched and acquired multiple businesses.
Its operating divisions now include Petauri Advance, Petauri Advisors, Petauri Evidence, Petauri Kinect, Petauri MAx, and Artia Solutions.
The organization employs more than 600 professionals globally.
Its customers include hundreds of pharmaceutical and life sciences companies seeking support with communicating the clinical, economic, and broader value of medical treatments.
Oak Hill Capital has committed to investing more than $250 million in equity capital toward the development of Petauri’s platform through its sixth fund.
The acquisition of Emotive represents another step in expanding the company’s specialized capabilities.
Petauri expects the integration to strengthen its ability to support clients earlier in the development of new therapies and throughout subsequent commercialization activities.
By combining Emotive’s scientific and creative expertise with the existing Petauri Advance agencies, the company aims to provide a broader range of coordinated medical communications services worldwide.
KEY QUOTES:
“As therapies become increasingly complex, our clients need partners that can not only understand the science behind them but translate it for the people who ultimately shape patient care. Emotive does just that by bridging scientific precision and industry-recognized creativity to inspire change and help lifesaving treatments reach those who need them most.”
Dan Renick, CEO Of Petauri
“Joining Petauri represents an exciting next chapter for Emotive. Emotive was built to turn complex science into communications that inspire meaningful change. Together with Petauri, we can build on that ambition, expanding what we can bring to clients while preserving the partnership they value.”
Chris Edmonds, Founder And CEO Of Emotive
“The strength of this combination lies in the complementary expertise of our teams, our shared core values, and the aligned vision for the future of healthcare communications. Together, our teams bring specialized knowledge across geographies, therapeutic areas, and disciplines to deliver more connected, impactful solutions earlier in the asset life cycle, ultimately helping to improve patient outcomes.”
Lisa Hefner, Group President Of Petauri Advance

